Roswell Park Cancer Institute: Carcinoma, Non-Small-Cell Lung trials

The registry lists 27 Carcinoma, Non-Small-Cell Lung studies with Roswell Park Cancer Institute as lead sponsor. 2 are open to participants now and 7 have results posted.

Early Phase 1 3Phase 1 12Phase 2 11No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung CancerRecruitingNCT07017829Phase 2
• Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung CancerRecruitingNCT05292521Not applicable
• Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small Cell Lung CancerActive, not recruitingNCT04032418Phase 2Results posted
• Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung CancerCompletedNCT03735095Phase 1/2Results posted
• Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation TherapyTerminatedNCT02452463Phase 2Results posted
• Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy RegimensCompletedNCT01948141Phase 2Results posted
• Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerCompletedNCT00843726Phase 2Results posted
• Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryTerminatedNCT00526890Phase 2Results posted
• Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00248495Phase 2Results posted
• Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung CancerWithdrawnNCT06943664Phase 2
• An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung CancerWithdrawnNCT06427369Phase 1
• A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung CancerActive, not recruitingNCT05138900Not applicable
• Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural DiseaseTerminatedNCT04836429Phase 1
• A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or RecurrenceCompletedNCT04298606Early Phase 1
• Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung CancerActive, not recruitingNCT04073745Phase 1
• Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing SurgeryCompletedNCT03678350Phase 1
• Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung CancerTerminatedNCT03348748Early Phase 1
• CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck CancerActive, not recruitingNCT02955290Phase 1/2
• Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT02947386Phase 1
• Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsWithdrawnNCT01971489Phase 1
• Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by SurgeryCompletedNCT01854684Phase 1
• Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung CancerCompletedNCT01781741Early Phase 1
• Photodynamic Therapy in Treating Patients With Lung CancerCompletedNCT01668823Phase 1
• Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung MetastasisCompletedNCT01014598Phase 1
• Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by SurgeryCompletedNCT00732563Not applicable
• Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerWithdrawnNCT00560495Phase 1
• Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryCompletedNCT00057798Phase 2